Metabolic phenotype in the mouse model of osteogenesis imperfecta

Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2. Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose...

Full description

Saved in:
Bibliographic Details
Published inJournal of endocrinology Vol. 234; no. 3; pp. 279 - 289
Main Authors Boraschi-Diaz, Iris, Tauer, Josephine T, El-Rifai, Omar, Guillemette, Delphine, Lefebvre, Geneviève, Rauch, Frank, Ferron, Mathieu, Komarova, Svetlana V
Format Journal Article
LanguageEnglish
Published England Bioscientifica Ltd 01.09.2017
Portland Press Ltd The Biochemical Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2. Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O2 consumption and CO2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin.
AbstractList Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2. Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O2 consumption and CO2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin.
Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2 . Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1 Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O 2 consumption and CO 2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin.
Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, or Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1 mouse, a model of dominant OI caused by a mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O consumption and CO production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin.
Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2 Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O2 consumption and CO2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin.Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2 Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O2 consumption and CO2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin.
Author Guillemette, Delphine
Ferron, Mathieu
Komarova, Svetlana V
Lefebvre, Geneviève
Boraschi-Diaz, Iris
Tauer, Josephine T
Rauch, Frank
El-Rifai, Omar
AuthorAffiliation Unité de Recherche en Physiologie Intégrative et Moléculaire, Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada
Shriners Hospital for Children-Canada, Montreal, Quebec, Canada
Département de Mathématiques, Université du Québec à Montréal, Montréal, Québec, Canada
Faculty of Dentistry, McGill University, Montreal, Quebec, Canada
Départements de Médecine et de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Québec, Canada
AuthorAffiliation_xml – name: Département de Mathématiques, Université du Québec à Montréal, Montréal, Québec, Canada
– name: Shriners Hospital for Children-Canada, Montreal, Quebec, Canada
– name: Unité de Recherche en Physiologie Intégrative et Moléculaire, Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada
– name: Départements de Médecine et de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Québec, Canada
– name: Faculty of Dentistry, McGill University, Montreal, Quebec, Canada
Author_xml – sequence: 1
  givenname: Iris
  surname: Boraschi-Diaz
  fullname: Boraschi-Diaz, Iris
  organization: Faculty of Dentistry, McGill University, Montreal, Quebec, Canada
– sequence: 2
  givenname: Josephine T
  surname: Tauer
  fullname: Tauer, Josephine T
  organization: Shriners Hospital for Children-Canada, Montreal, Quebec, Canada
– sequence: 3
  givenname: Omar
  surname: El-Rifai
  fullname: El-Rifai, Omar
  organization: Unité de Recherche en Physiologie Intégrative et Moléculaire, Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada
– sequence: 4
  givenname: Delphine
  surname: Guillemette
  fullname: Guillemette, Delphine
  organization: Département de Mathématiques, Université du Québec à Montréal, Montréal, Québec, Canada
– sequence: 5
  givenname: Geneviève
  surname: Lefebvre
  fullname: Lefebvre, Geneviève
  organization: Département de Mathématiques, Université du Québec à Montréal, Montréal, Québec, Canada
– sequence: 6
  givenname: Frank
  surname: Rauch
  fullname: Rauch, Frank
  organization: Shriners Hospital for Children-Canada, Montreal, Quebec, Canada
– sequence: 7
  givenname: Mathieu
  surname: Ferron
  fullname: Ferron, Mathieu
  organization: Départements de Médecine et de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Québec, Canada
– sequence: 8
  givenname: Svetlana V
  surname: Komarova
  fullname: Komarova, Svetlana V
  email: svetlana.komarova@mcgill.ca
  organization: Faculty of Dentistry, McGill University, Montreal, Quebec, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28716975$$D View this record in MEDLINE/PubMed
BookMark eNp90D1PwzAQBmALgWgLTOwoEgsSCtixHdtjVZUvgbrAHDnJmbpK7BA7Q_89qQoMHVjuluc-9M7QsfMOELok-I5wiu9fVsuUiBRTyo_QlDCh0lxifoymGGdZioXiEzQLYYMx4UTQUzTJpCC5EnyK5m8QdekbWyXdGpyP2w4S65K4hqT1Q9jVGprEm8SHCP4THAQbEtt20Buooj5HJ0Y3AS5--hn6eFi-L57S19Xj82L-mpaUq5jqUnJWa5aTGnRJhaFUSMkMz0AzXivFS5qJWmghGabAcoFlLmltMDXGVJqeoZv93q73XwOEWLQ2VNA02sH4aEFURghlivORXh_QjR96N343KsmoJFzJUV39qKFsoS663ra63xa_4Yzgdg-q3ofQg_kjBBe76Isx-oKIYhf9qMmBrmzU0XoXe22b_2dK60NlwUVrbKX_vfMN_DyUoA
CitedBy_id crossref_primary_10_1021_acsptsci_3c00324
crossref_primary_10_1007_s00223_024_01320_2
crossref_primary_10_1038_s41413_020_00122_0
crossref_primary_10_1159_000481918
crossref_primary_10_1016_j_ymgme_2021_02_004
crossref_primary_10_1016_j_bonr_2018_06_008
crossref_primary_10_1002_jbmr_4529
crossref_primary_10_3390_cells9122630
crossref_primary_10_1016_j_ymgme_2022_06_004
crossref_primary_10_3390_ijms22094963
crossref_primary_10_3390_ijms24010184
crossref_primary_10_1016_j_ymgme_2021_03_014
crossref_primary_10_1093_jbmrpl_ziae112
crossref_primary_10_3390_cells11233943
crossref_primary_10_1002_jbmr_3732
crossref_primary_10_1080_03008207_2022_2161376
crossref_primary_10_1002_jbm4_10753
crossref_primary_10_1007_s11914_018_0456_6
crossref_primary_10_1038_s44161_022_00018_8
crossref_primary_10_3390_ijms22010429
crossref_primary_10_1016_j_bone_2021_115940
crossref_primary_10_1371_journal_pgen_1008938
crossref_primary_10_1002_1873_3468_14259
Cites_doi 10.1016/j.molmet.2016.07.002
10.1111/j.1469-185X.1974.tb01171.x
10.1016/j.jpeds.2015.10.058
10.1097/BRS.0b013e31811ec2d9
10.1016/j.bone.2015.05.019
10.1007/s11832-012-0385-3
10.1161/ATVBAHA.110.204859
10.1016/j.nut.2011.04.003
10.1016/j.bone.2011.06.018
10.1073/pnas.0711119105
10.1359/jbmr.091109
10.1016/j.cell.2007.05.047
10.1016/j.bbrc.2010.06.008
10.1007/s00431-016-2839-y
10.1210/endo.143.5.8807
10.1210/jc.2008-1422
10.1007/s00198-016-3501-2
10.1083/jcb.201409111
10.1016/S8756-3282(00)00269-6
10.1038/nature10763
10.1002/jbmr.2177
10.1038/nrendo.2011.81
10.1359/jbmr.090720
10.1542/peds.49.3.375
10.1016/j.molmet.2013.08.004
10.1359/jbmr.081225
10.1016/j.bone.2014.06.015
10.1016/j.cell.2010.06.003
10.1136/adc.86.5.356
10.1016/j.bone.2014.10.012
10.1016/j.bone.2011.04.017
10.1359/JBMR.040111
10.1056/NEJM199810013391402
10.1038/382448a0
10.1016/j.bone.2015.08.001
10.1080/01621459.1963.10500845
10.1359/jbmr.080804
10.2353/ajpath.2010.090704
10.1038/pr.2015.230
ContentType Journal Article
Copyright 2017 Society for Endocrinology
2017 Society for Endocrinology.
Copyright Portland Press Ltd The Biochemical Society Sep 2017
Copyright_xml – notice: 2017 Society for Endocrinology
– notice: 2017 Society for Endocrinology.
– notice: Copyright Portland Press Ltd The Biochemical Society Sep 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
7X8
DOI 10.1530/JOE-17-0335
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate Metabolic phenotype in OI
EISSN 1479-6805
EndPage 289
ExternalDocumentID 28716975
10_1530_JOE_17_0335
Genre Journal Article
GroupedDBID -
02
08R
0R
2WC
3O-
4.4
53G
55
5GY
5RE
5VS
AAFZV
AAYJJ
ABFLS
ABLYK
ABOCM
ABPTK
ABSGY
ABSQV
ACNCT
ACPRK
ADACO
ADBBV
ADBIT
ADDZX
AENEX
AFDAS
AFFNX
AGCAB
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FA8
FH7
GJ
GX1
H13
HZ
H~9
IL9
INIJC
J5H
K-O
KM
KQ8
L7B
MVM
O0-
O9-
OHT
OK1
P2P
REN
RHF
TBS
VH1
WH7
WOQ
X
X7M
XJT
ZA5
ZGI
ZXP
---
-~X
.55
.GJ
0R~
18M
AALGN
AAYXX
ACGFO
ADMOG
AFHIN
AFOSN
AI.
BTFSW
CITATION
F9R
HF~
HZ~
W8F
WHG
~02
~KM
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
7X8
ID FETCH-LOGICAL-b359t-ab854da461deab37f337884f52ea45d995b327d7a78403e46708683df03fffca3
ISSN 0022-0795
1479-6805
IngestDate Fri Jul 11 01:22:20 EDT 2025
Mon Jun 30 11:35:55 EDT 2025
Thu Apr 03 07:04:27 EDT 2025
Thu Apr 24 22:58:51 EDT 2025
Thu Jul 03 08:36:15 EDT 2025
Wed Apr 14 02:20:59 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords glucose homeostasis
undercarboxylated osteocalcin
metabolism
osteogenesis imperfecta
indirect calorimetry
Language English
License 2017 Society for Endocrinology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b359t-ab854da461deab37f337884f52ea45d995b327d7a78403e46708683df03fffca3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://dx.doi.org/10.1530/JOE-17-0335
PMID 28716975
PQID 1984381598
PQPubID 2046244
PageCount 11
ParticipantIDs proquest_miscellaneous_1921134955
proquest_journals_1984381598
pubmed_primary_28716975
crossref_primary_10_1530_JOE_17_0335
crossref_citationtrail_10_1530_JOE_17_0335
bioscientifica_primary_10_1530_JOE_17_0335
PublicationCentury 2000
PublicationDate 20170900
2017-09-00
2017-Sep
20170901
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 20170900
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bristol
PublicationTitle Journal of endocrinology
PublicationTitleAlternate J Endocrinol
PublicationYear 2017
Publisher Bioscientifica Ltd
Portland Press Ltd The Biochemical Society
Publisher_xml – name: Bioscientifica Ltd
– name: Portland Press Ltd The Biochemical Society
References (ref421) 2015; 81
(ref831) 2003; 12
(ref201) 2017; 176
(ref381) 2015; 79
(ref761) 2014; 66
(ref51) 2014; 29
(ref601) 1998; 339
(ref771) 2010; 30
(ref161) 2012; 50
(ref131) 2012; 50
(ref801) 2015; 79
(ref511) 1996; 382
(ref311) 2000; 26
(ref401) 2007; 32
(ref31) 2016; 27
(ref571) 2011; 7
(ref231) 2004; 19
(ref621) 2017; 176
(ref331) 2012
(ref661) 2013; 2
(ref101) 2008; 105
(ref521) 2008; 105
(ref111) 2010a; 142
(ref151) 2011; 7
(ref61) 2009; 24
(ref361) 2015; 71
(ref681) 2010; 176
(ref261) 2010; 176
(ref791) 2008; 23
(ref491) 1972; 49
(ref301) 2014; 14
(ref591) 2016; 79
(ref611) 1974; 49
(ref371) 2008; 23
(ref211) 2002; 143
(ref21) 2002; 86
(ref711) 2009; 94
(ref191) 1974; 49
(ref321) 2010; 25
(ref671) 2007; 130
(ref651) 2004; 19
(ref251) 2007; 130
(ref121) 2010b; 397
(ref701) 2016; 169
(ref291) 2009; 94
(ref221) 2012; 481
(ref01) 2015; 81
(ref141) 2015; 208
(ref81) 2010; 25
(ref481) 2009; 24
(ref451) 2016; 27
(ref641) 2012; 481
(ref471) 2014; 29
(ref551) 2012; 50
(ref11) 2012; 6
(ref721) 2014; 14
(ref341) 2014; 66
(ref631) 2002; 143
(ref91) 1996; 382
(ref581) 2012; 50
(ref561) 2015; 208
(ref431) 2012; 6
(ref411) 2003; 12
(ref691) 2016; 5
(ref461) 2012; 28
(ref501) 2010; 25
(ref741) 2010; 25
(ref241) 2013; 2
(ref71) 1972; 49
(ref441) 2002; 86
(ref181) 1998; 339
(ref41) 2012; 28
(ref541) 2010b; 397
(ref271) 2016; 5
(ref811) 1963; 58
(ref781) 2015; 71
(ref351) 2010; 30
(ref731) 2000; 26
(ref751) 2012
(ref281) 2016; 169
(ref531) 2010a; 142
(ref171) 2016; 79
(ref391) 1963; 58
(ref821) 2007; 32
References_xml – volume: 5
  start-page: 1042
  year: 2016
  ident: ref691
  article-title: Osteocalcin is necessary and sufficient to maintain muscle mass in older mice
  publication-title: Molecular Metabolism
  doi: 10.1016/j.molmet.2016.07.002
– volume: 12
  start-page: 77
  year: 2003
  ident: ref831
  article-title: Modern approach to children with osteogenesis imperfecta
  publication-title: Journal of Pediatric Orthopaedics B
– volume: 49
  start-page: 423
  year: 1974
  ident: ref611
  article-title: Sexual dimorphism in mammals
  publication-title: Biological Reviews
  doi: 10.1111/j.1469-185X.1974.tb01171.x
– volume: 169
  start-page: 232
  year: 2016
  ident: ref281
  article-title: Body Composition in Children and Adolescents with Osteogenesis Imperfecta
  publication-title: Journal of Pediatrics
  doi: 10.1016/j.jpeds.2015.10.058
– volume-title: Methods of Multivariate Analysis
  year: 2012
  ident: ref331
– volume: 32
  start-page: 488
  year: 2007
  ident: ref821
  article-title: Correlation of scoliotic curvature with Z-score bone mineral density and body mass index in patients with osteogenesis imperfecta
  publication-title: Spine
  doi: 10.1097/BRS.0b013e31811ec2d9
– volume: 79
  start-page: 52
  year: 2015
  ident: ref801
  article-title: The functional muscle-bone unit in patients with osteogenesis imperfecta type I
  publication-title: Bone
  doi: 10.1016/j.bone.2015.05.019
– volume: 6
  start-page: 29
  year: 2012
  ident: ref431
  article-title: A scoring system for the assessment of clinical severity in osteogenesis imperfecta
  publication-title: Journal of Children’s Orthopaedics
  doi: 10.1007/s11832-012-0385-3
– volume: 30
  start-page: 1474
  year: 2010
  ident: ref771
  article-title: Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
  doi: 10.1161/ATVBAHA.110.204859
– volume: 28
  start-page: 138
  year: 2012
  ident: ref461
  article-title: Do patients with osteogenesis imperfecta need individualized nutritional support?
  publication-title: Nutrition
  doi: 10.1016/j.nut.2011.04.003
– volume: 50
  start-page: 452
  year: 2012
  ident: ref161
  article-title: Novel functions for insulin in bone
  publication-title: Bone
  doi: 10.1016/j.bone.2011.06.018
– volume: 105
  start-page: 5266
  year: 2008
  ident: ref101
  article-title: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.
  publication-title: PNAS
  doi: 10.1073/pnas.0711119105
– volume: 25
  start-page: 1367
  year: 2010
  ident: ref741
  article-title: Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/jbmr.091109
– volume: 130
  start-page: 456
  year: 2007
  ident: ref671
  article-title: Endocrine regulation of energy metabolism by the skeleton
  publication-title: Cell
  doi: 10.1016/j.cell.2007.05.047
– volume: 397
  start-page: 691
  year: 2010b
  ident: ref541
  article-title: An ELISA-based method to quantify osteocalcin carboxylation in mice
  publication-title: Biochemical and Biophysical Research Communications
  doi: 10.1016/j.bbrc.2010.06.008
– volume: 176
  start-page: 311
  year: 2017
  ident: ref201
  article-title: Developmental charts for children with osteogenesis imperfecta, type I (body height, body weight and BMI)
  publication-title: European Journal of Pediatrics
  doi: 10.1007/s00431-016-2839-y
– volume: 143
  start-page: 1594
  year: 2002
  ident: ref211
  article-title: Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse
  publication-title: Endocrinology
  doi: 10.1210/endo.143.5.8807
– volume: 94
  start-page: 827
  year: 2009
  ident: ref291
  article-title: Association between serum osteocalcin and markers of metabolic phenotype
  publication-title: Journal of Clinical Endocrinology and Metabolism
  doi: 10.1210/jc.2008-1422
– volume: 27
  start-page: 2355
  year: 2016
  ident: ref31
  article-title: Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α
  publication-title: Osteoporosis International
  doi: 10.1007/s00198-016-3501-2
– volume: 208
  start-page: 761
  year: 2015
  ident: ref141
  article-title: GGCX and VKORC1 inhibit osteocalcin endocrine functions
  publication-title: Journal of Cell Biology
  doi: 10.1083/jcb.201409111
– volume: 26
  start-page: 581
  year: 2000
  ident: ref311
  article-title: Static and dynamic bone histomorphometry in children with osteogenesis imperfecta
  publication-title: Bone
  doi: 10.1016/S8756-3282(00)00269-6
– volume: 481
  start-page: 314
  year: 2012
  ident: ref641
  article-title: The contribution of bone to whole-organism physiology
  publication-title: Nature
  doi: 10.1038/nature10763
– volume: 49
  start-page: 423
  year: 1974
  ident: ref191
  article-title: Sexual dimorphism in mammals
  publication-title: Biological Reviews
  doi: 10.1111/j.1469-185X.1974.tb01171.x
– volume: 29
  start-page: 1412
  year: 2014
  ident: ref51
  article-title: First mouse model for combined osteogenesis imperfecta and ehlers-danlos syndrome
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1002/jbmr.2177
– volume: 7
  start-page: 540
  year: 2011
  ident: ref151
  article-title: New perspectives on osteogenesis imperfecta
  publication-title: Nature Reviews Endocrinology
  doi: 10.1038/nrendo.2011.81
– volume: 25
  start-page: 247
  year: 2010
  ident: ref81
  article-title: Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/jbmr.090720
– volume: 49
  start-page: 375
  year: 1972
  ident: ref491
  article-title: Physiological evidence of hypermetabolism in osteogenesis imperfecta
  publication-title: Pediatrics
  doi: 10.1542/peds.49.3.375
– volume: 2
  start-page: 498
  year: 2013
  ident: ref661
  article-title: In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice
  publication-title: Molecular Metabolism
  doi: 10.1016/j.molmet.2013.08.004
– volume: 176
  start-page: 311
  year: 2017
  ident: ref621
  article-title: Developmental charts for children with osteogenesis imperfecta, type I (body height, body weight and BMI)
  publication-title: European Journal of Pediatrics
  doi: 10.1007/s00431-016-2839-y
– volume: 25
  start-page: 1367
  year: 2010
  ident: ref321
  article-title: Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/jbmr.091109
– volume: 24
  start-page: 669–
  year: 2009
  ident: ref481
  article-title: Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/jbmr.081225
– volume: 66
  start-page: 182
  year: 2014
  ident: ref761
  article-title: Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta
  publication-title: Bone
  doi: 10.1016/j.bone.2014.06.015
– volume: 142
  start-page: 296
  year: 2010a
  ident: ref111
  article-title: Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism
  publication-title: Cell
  doi: 10.1016/j.cell.2010.06.003
– volume: 481
  start-page: 314
  year: 2012
  ident: ref221
  article-title: The contribution of bone to whole-organism physiology
  publication-title: Nature
  doi: 10.1038/nature10763
– volume: 28
  start-page: 138
  year: 2012
  ident: ref41
  article-title: Do patients with osteogenesis imperfecta need individualized nutritional support?
  publication-title: Nutrition
  doi: 10.1016/j.nut.2011.04.003
– volume: 86
  start-page: 356
  year: 2002
  ident: ref21
  article-title: Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
  publication-title: Archives of Disease in Childhood
  doi: 10.1136/adc.86.5.356
– volume: 71
  start-page: 115
  year: 2015
  ident: ref361
  article-title: Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment
  publication-title: Bone
  doi: 10.1016/j.bone.2014.10.012
– volume: 50
  start-page: 568
  year: 2012
  ident: ref551
  article-title: Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice
  publication-title: Bone
  doi: 10.1016/j.bone.2011.04.017
– volume: 19
  start-page: 614
  year: 2004
  ident: ref231
  article-title: Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/JBMR.040111
– volume: 143
  start-page: 1594
  year: 2002
  ident: ref631
  article-title: Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse
  publication-title: Endocrinology
  doi: 10.1210/endo.143.5.8807
– volume: 14
  start-page: 155
  year: 2014
  ident: ref721
  article-title: Validity of an accelerometer as a vertical ground reaction force measuring device in healthy children and adolescents and in children and adolescents with osteogenesis imperfecta type I
  publication-title: Journal of Musculoskeletal and Neuronal Interactions
– volume: 339
  start-page: 947
  year: 1998
  ident: ref601
  article-title: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJM199810013391402
– volume: 7
  start-page: 540
  year: 2011
  ident: ref571
  article-title: New perspectives on osteogenesis imperfecta
  publication-title: Nature Reviews Endocrinology
  doi: 10.1038/nrendo.2011.81
– volume: 382
  start-page: 448
  year: 1996
  ident: ref91
  article-title: Increased bone formation in osteocalcin-deficient mice
  publication-title: Nature
  doi: 10.1038/382448a0
– volume: 94
  start-page: 827
  year: 2009
  ident: ref711
  article-title: Association between serum osteocalcin and markers of metabolic phenotype
  publication-title: Journal of Clinical Endocrinology and Metabolism
  doi: 10.1210/jc.2008-1422
– volume: 79
  start-page: 52
  year: 2015
  ident: ref381
  article-title: The functional muscle-bone unit in patients with osteogenesis imperfecta type I
  publication-title: Bone
  doi: 10.1016/j.bone.2015.05.019
– volume: 81
  start-page: 400–
  year: 2015
  ident: ref421
  article-title: Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta
  publication-title: Bone
  doi: 10.1016/j.bone.2015.08.001
– volume: 169
  start-page: 232
  year: 2016
  ident: ref701
  article-title: Body Composition in Children and Adolescents with Osteogenesis Imperfecta
  publication-title: Journal of Pediatrics
  doi: 10.1016/j.jpeds.2015.10.058
– volume: 208
  start-page: 761
  year: 2015
  ident: ref561
  article-title: GGCX and VKORC1 inhibit osteocalcin endocrine functions
  publication-title: Journal of Cell Biology
  doi: 10.1083/jcb.201409111
– volume: 6
  start-page: 29
  year: 2012
  ident: ref11
  article-title: A scoring system for the assessment of clinical severity in osteogenesis imperfecta
  publication-title: Journal of Children’s Orthopaedics
  doi: 10.1007/s11832-012-0385-3
– volume: 339
  start-page: 947
  year: 1998
  ident: ref181
  article-title: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJM199810013391402
– volume: 5
  start-page: 1042
  year: 2016
  ident: ref271
  article-title: Osteocalcin is necessary and sufficient to maintain muscle mass in older mice
  publication-title: Molecular Metabolism
  doi: 10.1016/j.molmet.2016.07.002
– volume: 26
  start-page: 581
  year: 2000
  ident: ref731
  article-title: Static and dynamic bone histomorphometry in children with osteogenesis imperfecta
  publication-title: Bone
  doi: 10.1016/S8756-3282(00)00269-6
– volume: 19
  start-page: 614
  year: 2004
  ident: ref651
  article-title: Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/JBMR.040111
– volume-title: Methods of Multivariate Analysis
  year: 2012
  ident: ref751
– volume: 50
  start-page: 568
  year: 2012
  ident: ref131
  article-title: Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice
  publication-title: Bone
  doi: 10.1016/j.bone.2011.04.017
– volume: 49
  start-page: 375
  year: 1972
  ident: ref71
  article-title: Physiological evidence of hypermetabolism in osteogenesis imperfecta
  publication-title: Pediatrics
  doi: 10.1542/peds.49.3.375
– volume: 58
  start-page: 236
  year: 1963
  ident: ref391
  article-title: Hierarchical grouping to optimize an objective function
  publication-title: Journal of the American Statistical Association
  doi: 10.1080/01621459.1963.10500845
– volume: 397
  start-page: 691
  year: 2010b
  ident: ref121
  article-title: An ELISA-based method to quantify osteocalcin carboxylation in mice
  publication-title: Biochemical and Biophysical Research Communications
  doi: 10.1016/j.bbrc.2010.06.008
– volume: 29
  start-page: 1412
  year: 2014
  ident: ref471
  article-title: First mouse model for combined osteogenesis imperfecta and ehlers-danlos syndrome
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1002/jbmr.2177
– volume: 142
  start-page: 296
  year: 2010a
  ident: ref531
  article-title: Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism
  publication-title: Cell
  doi: 10.1016/j.cell.2010.06.003
– volume: 66
  start-page: 182
  year: 2014
  ident: ref341
  article-title: Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta
  publication-title: Bone
  doi: 10.1016/j.bone.2014.06.015
– volume: 24
  start-page: 669–
  year: 2009
  ident: ref61
  article-title: Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/jbmr.081225
– volume: 27
  start-page: 2355
  year: 2016
  ident: ref451
  article-title: Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α
  publication-title: Osteoporosis International
  doi: 10.1007/s00198-016-3501-2
– volume: 30
  start-page: 1474
  year: 2010
  ident: ref351
  article-title: Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
  doi: 10.1161/ATVBAHA.110.204859
– volume: 2
  start-page: 498
  year: 2013
  ident: ref241
  article-title: In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice
  publication-title: Molecular Metabolism
  doi: 10.1016/j.molmet.2013.08.004
– volume: 71
  start-page: 115
  year: 2015
  ident: ref781
  article-title: Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment
  publication-title: Bone
  doi: 10.1016/j.bone.2014.10.012
– volume: 23
  start-page: 1983
  year: 2008
  ident: ref371
  article-title: Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/jbmr.080804
– volume: 176
  start-page: 2405
  year: 2010
  ident: ref681
  article-title: Immature Osteoblast Lineage Cells Increase Osteoclastogenesis in Osteogenesis Imperfecta Murine
  publication-title: American Journal of Pathology
  doi: 10.2353/ajpath.2010.090704
– volume: 23
  start-page: 1983
  year: 2008
  ident: ref791
  article-title: Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/jbmr.080804
– volume: 81
  start-page: 400–
  year: 2015
  ident: ref01
  article-title: Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta
  publication-title: Bone
  doi: 10.1016/j.bone.2015.08.001
– volume: 14
  start-page: 155
  year: 2014
  ident: ref301
  article-title: Validity of an accelerometer as a vertical ground reaction force measuring device in healthy children and adolescents and in children and adolescents with osteogenesis imperfecta type I
  publication-title: Journal of Musculoskeletal and Neuronal Interactions
– volume: 58
  start-page: 236
  year: 1963
  ident: ref811
  article-title: Hierarchical grouping to optimize an objective function
  publication-title: Journal of the American Statistical Association
  doi: 10.1080/01621459.1963.10500845
– volume: 79
  start-page: 489
  year: 2016
  ident: ref591
  article-title: Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care
  publication-title: Pediatric Research
  doi: 10.1038/pr.2015.230
– volume: 86
  start-page: 356
  year: 2002
  ident: ref441
  article-title: Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
  publication-title: Archives of Disease in Childhood
  doi: 10.1136/adc.86.5.356
– volume: 32
  start-page: 488
  year: 2007
  ident: ref401
  article-title: Correlation of scoliotic curvature with Z-score bone mineral density and body mass index in patients with osteogenesis imperfecta
  publication-title: Spine
  doi: 10.1097/BRS.0b013e31811ec2d9
– volume: 12
  start-page: 77
  year: 2003
  ident: ref411
  article-title: Modern approach to children with osteogenesis imperfecta
  publication-title: Journal of Pediatric Orthopaedics B
– volume: 382
  start-page: 448
  year: 1996
  ident: ref511
  article-title: Increased bone formation in osteocalcin-deficient mice
  publication-title: Nature
  doi: 10.1038/382448a0
– volume: 105
  start-page: 5266
  year: 2008
  ident: ref521
  article-title: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.
  publication-title: PNAS
  doi: 10.1073/pnas.0711119105
– volume: 176
  start-page: 2405
  year: 2010
  ident: ref261
  article-title: Immature Osteoblast Lineage Cells Increase Osteoclastogenesis in Osteogenesis Imperfecta Murine
  publication-title: American Journal of Pathology
  doi: 10.2353/ajpath.2010.090704
– volume: 79
  start-page: 489
  year: 2016
  ident: ref171
  article-title: Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care
  publication-title: Pediatric Research
  doi: 10.1038/pr.2015.230
– volume: 25
  start-page: 247
  year: 2010
  ident: ref501
  article-title: Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model
  publication-title: Journal of Bone and Mineral Research
  doi: 10.1359/jbmr.090720
– volume: 130
  start-page: 456
  year: 2007
  ident: ref251
  article-title: Endocrine regulation of energy metabolism by the skeleton
  publication-title: Cell
  doi: 10.1016/j.cell.2007.05.047
– volume: 50
  start-page: 452
  year: 2012
  ident: ref581
  article-title: Novel functions for insulin in bone
  publication-title: Bone
  doi: 10.1016/j.bone.2011.06.018
SSID ssj0015173
Score 2.346409
Snippet Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I...
SourceID proquest
pubmed
crossref
bioscientifica
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 279
SubjectTerms Adipose tissue
Animals
Bone growth
Bone resorption
Calorimetry
Carbon dioxide
Collagen (type I)
Collagen Type I - genetics
Collagen Type I - metabolism
Disease Models, Animal
Energy expenditure
Energy metabolism
Female
Genotype & phenotype
Glucose tolerance
Hereditary diseases
Homeostasis
Humans
Insulin
Insulin secretion
Male
Metabolism
Mice
Mutation
Osteocalcin
Osteocalcin - genetics
Osteocalcin - metabolism
Osteogenesis
Osteogenesis imperfecta
Osteogenesis Imperfecta - genetics
Osteogenesis Imperfecta - metabolism
Phenotype
Rodents
Secretion
Title Metabolic phenotype in the mouse model of osteogenesis imperfecta
URI http://dx.doi.org/10.1530/JOE-17-0335
https://www.ncbi.nlm.nih.gov/pubmed/28716975
https://www.proquest.com/docview/1984381598
https://www.proquest.com/docview/1921134955
Volume 234
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBBIINj4GAxkpIkHJLO2tvPxWKDbhNpVQq3UN8tObBSpTdCWPsBfz52dph10aPASVanjRHfn8935d3eEHCfCSS5MxBxoPiaE6zGthWZgysrMpLBDdjF3eHwRnc_El7mcdzqjLdTSqjYfsp8780r-h6twD_iKWbL_wNl2UrgBv4G_cAUOw_VWPB7bGniIZaoRqVX5cGqDW0SP3oY-N2gPYipH9Q31WnGFmZH2EmEc-gbT1JZ5Bdrkesj9IwgLuMIF-1xoH3XG5vQbx38VeB9OFNB0bdHXwwX7WrjQ9nqy1C0a-GyFeYhLxBoFzbfwD27HIWBvWwOt1qpTxCmLkm44o7Y77jX6tt9EL4ttfzxoz9BX5g-tLrlvWD0ZMnwt53Kzea0P7C8m6nQ2GqnpcD69Q-72wWnAfhZn8xbwA6aNxxu039Rka8LkJ1tTPyAPTRHqiHqw1m8Gyw1eiLdGpo_Jo4ZXdBBk4gnp2HKfHAxKXVfLH_Qd9cBez759cm_c4CcOyKCVGNpKDC1KChJDvcRQLzG0cnRbYuhGYp6S2elw-umcNU00mOEyrZk2iRS5FlEvt9rw2HHsIAArtG-1kHmaSsP7cR7rGFx9bmHfBCc34bnrcudcpvkzsldWpX1BaCwyF2dJJjMBdqdMksylWSaSKDW5cTY-JO-vk059DxVTFHqaQGcFdFa9WCGdYfCarCprytFjV5TF7sHH7eC_znm05o9qlumV6qUJlrGTaXJI3rZ_gxLFkzFdWiCuwqKAWKdTwhTPA1_b9_iQQhrLl7d4-hW5v1kaR2SvvlzZ12C01uaNl8Vf8Q2Xuw
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+phenotype+in+the+mouse+model+of+osteogenesis+imperfecta&rft.jtitle=Journal+of+endocrinology&rft.au=Boraschi-Diaz%2C+Iris&rft.au=Tauer%2C+Josephine+T&rft.au=El-Rifai%2C+Omar&rft.au=Guillemette%2C+Delphine&rft.date=2017-09-01&rft.issn=1479-6805&rft.eissn=1479-6805&rft.volume=234&rft.issue=3&rft.spage=279&rft_id=info:doi/10.1530%2FJOE-17-0335&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-0795&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-0795&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-0795&client=summon